*Aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy or following disease progression on endocrine th...
| Brand Name | Manufacturer / Company | Available Pack Sizes & Price | Action |
|---|---|---|---|
| KISQALI | 🏢 NOVARTIS |
Tab 200 mg 21:
Rs.577884.70
Tab 200 mg 42:
Rs.316667.00
Tab 200 mg 63:
Rs.577884.70
|
View Details → |